Оценка эффективности препарата «нуклео цмф форте» в комплексном лечении диабетических полинейропатий

Аннотация

Study included 49 patients with type 2 diabetes (18 men and 31 women) patients were divided into two groups. Patients core (n = 28) and a comparison group (n = 21). Patients of the group, along with the complex therapy received glucose-lowering therapy, drugs with alpha-lipoic acid, В vitamins, as well as in the treatment of complex was added to the drug-Nucleo CMP Forte. Patients comparison group received all of the above drugs, except Nucleo CMP Forte. Results In general, the effectiveness of combined therapy with the addition of the preparation of CMP Nucleo fort in all cases were satisfactory, since improvement in NDS NSS and ranged from 40% to 80%, averaging 66.5%. Patients reported less pain on feet, especially at night. Also noted a decrease in feelings of injection on the side. Also noted a positive trend in terms of carbohydrate metabolism. Conclusion The tests showed that the addition of the complex treatment of diabetic neuropathy drug Nucleo CMP Forte positive impact on the state of the peripheral nervous system, as indicated by a significant decrease in performance NSS and NDS by 66 and 43%, respectively.